GlassScriptPhysician profile
Tara L Bruce
NPI 1326023946
$3,034.36
in general payments reported to CMS, 2019-2025
33 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $293 · 2021: $410 · 2022: $711 · 2023: $700 · 2024: $224 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,095.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,048.75 | 2019-2023 | Lo Loestrin Fe, Orilissa, Botox |
| Sumitomo Pharma America, INC. | $209.56 | 2023 | Myfembree |
| Exeltis, USA INC. | $202.80 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $148.97 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $133.97 | 2019-2023 | |
| Astellas Pharma US INC | $133.13 | 2022-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $105.65 | 2019-2023 | Paragard T 380a |
| Myovant Sciences INC. | $96.29 | 2022 | |
| Pfizer INC. | $95.50 | 2022-2024 | |
| Agile Therapeutics, INC. | $87.23 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $67.47 | 2022-2024 | |
| Organon LLC | $66.60 | 2021-2022 | |
| Renovia INC | $52.90 | 2019 | |
| Medicem INC. | $52.37 | 2021-2022 | |
| Lupin INC. | $45.28 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $43.21 | 2024-2025 | Zurzuvae |
| Applied Medical Resources Corporation | $41.28 | 2025 | |
| Duchesnay USA Incorporated | $37.36 | 2019 | |
| Therapeuticsmd, INC. | $36.07 | 2019-2022 | |
| Evofem Biosciences, INC. | $35.61 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $33.57 | 2019-2021 | |
| Allergan, INC. | $29.66 | 2019-2020 | |
| Avion Pharmaceuticals | $28.87 | 2020-2021 | |
| Smith+Nephew, INC. | $28.59 | 2024 | Pico 7 |
| Amgen INC. | $28.47 | 2019-2023 | Prolia |
| Axonics, INC. | $24.38 | 2024 | Axonics |
| Medtronic, INC. | $22.27 | 2023 | V-Loc 180 |
| Vertical Pharmaceuticals, LLC | $20.77 | 2019 | |
| Alnylam Pharmaceuticals INC. | $16.50 | 2020 | |
| Amneal Pharmaceuticals LLC | $16.48 | 2025 | Unithroid |
| Biogen, INC. | $16.28 | 2020 | |
| Novo Nordisk INC | $14.64 | 2023 | Wegovy |
| Mylan Pharmaceuticals INC. | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Bruce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.